I collaborate with colleagues in India such as those from the Aravind Eye Institute in India to develop better methods for identifying individuals at higher risk for future blindness (so that they may be caught and treated early). We have also run clinical trials to improve treatment algorithms for patients with routine and complex eye conditions.